Bitcoin, Ethereum fall sharply as crypto sell-off resumes

Bitcoin, Ethereum fall sharply as crypto sell-off resumes


Bitcoin and Ethereum fell on Monday, as the recent sell-off in cryptocurrencies resumed.

Bitcoin tumbled sharply and was last seen around $86,553 at 8:18 a.m. in London on Monday, a slide of about 5.3%. Ethereum dropped around 6.4% in early trade, to reach $2,836.

Solana had fallen over 7%, and was last seen around $127, while other closely-watched tokens were also in the red, including Dogecoin, which slipped around 8%.

Stock Chart IconStock chart icon

hide content

BTC.

In Asia, a statement by the People’s Bank of China on Saturday warning of illegal activities relating to digital currencies heaped pressure on Hong Kong-listed shares of digital assets-related companies, which retreated during Monday’s session.

The fresh slide in digital assets chimes with a broader risk-off sentiment at the start of a new month.

Macroeconomic concerns — including uncertainty over a possible U.S. rate cut — continue to weigh on investors’ minds, while nagging doubts over overheated valuations in artificial intelligence-related names contributed to November’s bumpy markets as crypto volatility heightened.

Bitcoin's slump continues, falling towards $86,000



Source

The Tech Download: How Russia could profit from Iran war helium supply chain disruption in the chip sector
World

The Tech Download: How Russia could profit from Iran war helium supply chain disruption in the chip sector

This report is from this week’s The Tech Download newsletter. Like what you see? You can subscribe here. Helium has emerged as a key focus for the tech sector as industry watchers cast their minds to the implications of a prolonged Iran war. A byproduct of natural gas production, helium is crucial to semiconductor manufacturing and […]

Read More
Novartis shells out  billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week
World

Novartis shells out $2 billion for immunology biotech Excellergy, in second multi-billion dollar deal in a week

A sign of Swiss pharmaceutical giant Novartis is seen on the top of a building at Novartis Campus in Basel, northern Switzerland, on Sept. 9, 2025. Fabrice Coffrini | AFP | Getty Images Novartis is planning to buy U.S.-based biotech Excellergy for up to $2 billion, betting on a next-generation allergy treatment that may prove […]

Read More
U.S. ambassador to EU: Stop fining Big Tech
World

U.S. ambassador to EU: Stop fining Big Tech

The European Union needs to dial back regulation of U.S. big tech companies if it wants to be part of the AI economy, the U.S. ambassador to the EU Andrew Puzder told CNBC on Friday. “If the European Union is going to participate in the AI economy…They’re going to need data centers, data and access […]

Read More